# Expedia Group (EXPE): value investors who own it | moatshark

2 value investors held Expedia Group in their Q2 2026 13F, led by Patient Capital Management, Pzena Investment Management.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Patient Capital Management | 1.4% | $42.9m | Added 0.0% | 17 |
| Maverick Capital | 0.0% | $0k | Sold out | 2 |
| Pzena Investment Management | 0.0% | $271k | New | 1 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-08-24 | Dzielak Robert J | Chief Legal Officer & Sec'y | Sold | 1004 | $336k |
| 2026-08-18 | Soliday Lance A | SVP & Chief Accounting Officer | Sold | 2810 | $909k |
| 2026-08-17 | Dzielak Robert J | Chief Legal Officer & Sec'y | Sold | 2000 | $661k |
| 2026-08-13 | Jacobson Craig A | Director | Sold | 3133 | $1.0m |
| 2026-08-11 | Dzielak Robert J | Chief Legal Officer & Sec'y | Sold | 3003 | $946k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/expe). Values traded and returns are estimates. Not investment advice. Built 2026-10-23.